Literature DB >> 18078857

Leptin but not neuropeptide Y up-regulated glucagon-like peptide 1 receptor expression in GT1-7 cells and rat hypothalamic slices.

Carmen Sanz1, Patricia Vázquez, M Angeles Navas, Elvira Alvarez, Enrique Blázquez.   

Abstract

In an attempt to gain better insight into the central effects of glucagon-like peptide (GLP-1), we studied the action of glucose and of regulatory peptides on the expression of its receptor (GLP-1R) in hypothalamic GT1-7 cells and in ventromedial (VMH) and lateral (LH) rat hypothalamus slices. The promoter activity of GLP-1R in transfected GT1-7 cells increased with leptin, whereas neuropeptide Y (NPY) did not modify it. Interestingly, when cells were incubated with both NPY and leptin, NPY blocked the stimulating effect of leptin. The effects of leptin and NPY were also confirmed at messenger RNA levels. In hypothalamic slices, GLP-1R messenger RNA levels increased at higher glucose concentrations in the VMH. In addition, leptin exerted a stimulating effect; and NPY did not modify receptor expression. By contrast, in the LH, the opposite effects were found for those parameters, except at 20 mmol/L glucose. These findings suggest that the stimulating effect of leptin on GLP-1R expression, with no changes in NPY-induced activity, could enhance the anorexic actions generated through this receptor. In addition, the different responses of the VMH and LH may be related to specific functions of these structures, as already known in vivo, highlighting the interest of hypothalamic slices for this kind of study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18078857     DOI: 10.1016/j.metabol.2007.08.005

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

2.  Melanocortin-induced PKA activation inhibits AMPK activity via ERK-1/2 and LKB-1 in hypothalamic GT1-7 cells.

Authors:  Ellen Damm; Thomas R H Buech; Thomas Gudermann; Andreas Breit
Journal:  Mol Endocrinol       Date:  2012-02-23

3.  Cultured hypothalamic neurons are resistant to inflammation and insulin resistance induced by saturated fatty acids.

Authors:  Sun Ju Choi; Francis Kim; Michael W Schwartz; Brent E Wisse
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-30       Impact factor: 4.310

4.  Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.

Authors:  S E Kanoski; Z Y Ong; S M Fortin; E S Schlessinger; H J Grill
Journal:  Diabetes Obes Metab       Date:  2015-01-08       Impact factor: 6.577

5.  Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans.

Authors:  Eric M Snyder; Richard D Carr; Carolyn F Deacon; Bruce D Johnson
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

6.  PAS kinase as a nutrient sensor in neuroblastoma and hypothalamic cells required for the normal expression and activity of other cellular nutrient and energy sensors.

Authors:  Verónica Hurtado-Carneiro; Isabel Roncero; Enrique Blazquez; Elvira Alvarez; Carmen Sanz
Journal:  Mol Neurobiol       Date:  2013-06-14       Impact factor: 5.590

Review 7.  GLP-1 and weight loss: unraveling the diverse neural circuitry.

Authors:  Scott E Kanoski; Matthew R Hayes; Karolina P Skibicka
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-30       Impact factor: 3.619

8.  Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat.

Authors:  Indu Poornima; Suzanne B Brown; Siva Bhashyam; Pratik Parikh; Hakki Bolukoglu; Richard P Shannon
Journal:  Circ Heart Fail       Date:  2008-09       Impact factor: 8.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.